Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 66   

Articles published

PFE 32.40 +0.12 (0.37%)
price chart
Retailers sue Pfizer, charge generic Lipitor delay
The exterior of Pfizer in Groton, Conn. Pfizer Inc. Shares of Pfizer Inc. and Bristol-Myers Squibb Co. fell Monday, June 25, 2012, after federal regulators unexpectedly delayed for a second time a decision on whether to approve the companies' highly ...
Pharmacies Sue Pfizer Over Lipitor  Wall Street Journal
PFE Breaking Out After Long Series of Corrections
Pfizer Inc. (NYSE:PFE) - This is the world's largest pharmaceutical company producing a wide range of drugs. In October 2009, it acquired Wyeth.
Hopes dim for Alzheimer's trials after Pfizer failure
Investor hopes for two experimental Alzheimer's treatments have grown even fainter after Pfizer Inc said its treatment failed in one of four big clinical trials.
Pfizer-Janssen Alzheimer's Treatment Misses Phase III Endpoints  Genetic Engineering News
Alzheimer's Drug Fails a Late-Stage Clinical Trial  TIME
Is Pfizer A Good Buy?
Pfizer has been involved in a series of acquisitions and sell offs, some cheered and some criticized by investors. They recently sold off their nutrition business to Nestle for $11.9 billion.
Pfizer Posts Strong Profits, Faces Strong Headwinds
Steps are being made in a positive direction, as Pfizer plans to spin off up to 20 percent of its animal health business in an initial public offering (IPO) this August.
Business Day|Cost-Cutting Helps Pfizer Beat Analysts' Expectations  New York Times
Verastem Acquires Clinical-Stage FAK Inhibitor from Pfizer
BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced an agreement with Pfizer for the exclusive ...
For Pfizer, Boston's medical labs a lure
Pfizer Inc., the world's largest pharmaceutical company, has a storied history of hunting for blockbuster drugs in its own labs.
Pfizer Wins Lyrica Patent Ruling
A U.S. judge has upheld the validity of patents covering Pfizer Inc. PFE -1.11 % 's pain drug Lyrica, preserving market U.S.
Pfizer's Lyrica does not hurt sperm in study
Pfizer Inc said a clinical study found its Lyrica nerve pain treatment did not affect sperm production in men taking the pill.
Top-line results in Pfizer's Lyrica long term safety study for ...
Pfizer stops Teva selling generic Lyrica  Globes
Pfizer yanks breast, colon claims for Centrum vitamins
NEW YORK/WASHINGTON - Pfizer Inc, bowing to allegations of deceptive advertising lodged by a consumer watchdog group, has agreed to drop "breast health" and "colon health" claims from the labels of its widely used Centrum multivitamin supplements.